Latest News

Stay up to date with the latest developments in myasthenia gravis research, advocacy, and community support. Explore news, events, and policy updates to stay informed and get involved.

Browse our categories to explore stories relevant to you, and stay connected with the MG community.

All
  • All
  • About MAA News Items
  • Annual Conference News Items
  • Art With Heart News Items
  • Get Involved News Items
  • Health Professionals News Items
  • Living with MG News Items
  • MG Awareness Month News Items
  • Patient Tool Kit
  • Policy Makers News Items
  • Understanding MG News Items
canada-feat-image
Final Reminder – Partnering With Canada

To Australians with Myasthenia, the following is a message from Dr Carolina Barnette-Tapia MD, PhD of Canada. The MAA thank Australians for their interest in supporting this project. Responses will be welcomed until early September 2024. Information about the outcomes resulting from this research has been requested. Disclosure information is provided after logging in. “We…

Research-Report
Research Report

The Myasthenia Alliance Australia (MAA) supports and promotes research that is specific to the experience of Myasthenia Gravis (MG) patients in Australia. But we would not be able to do this without the essential and valuable contribution of Australians with MG. One current project is VALUE-Ig, which aims to generate evidence to inform the optimal…

canada-feat-image
Partnering With Canada

To Australians with Myasthenia, the following is a message from Dr Carolina Barnette-Tapia MD, PhD of Canada. The MAA thank Australians for their interest in supporting this project. Responses will be welcomed until early September 2024. Information about the outcomes resulting from this research has been requested. Disclosure information is provided after logging in. “We…

amplo-webinar-feat-image
Gene Therapy for Congenital Myasthenia Syndrome – Webinar Invitation

The MAA first engaged with Amplo Biotechnologies at the 2019 Brisbane Conference. We are delighted to report that Patricio Sepulveda, CEO, is offering to share updated information on “what they are doing and where they are at”. Patricio reports that 35 different genes have now been identified to capture more people with Congenital Myasthenia Syndrome.…

Make a submission to PBAC about a new complement inhibitor treatment, Zilucoplan

Make a submission to PBAC about a new complement inhibitor treatment, Zilucoplan

UPDATED – Participate in a focus group to help design research for MG patients

Participate in a focus group to help design research for MG patients

MAA-Couch-Consumer-300x205
Couch Consumer Research

Couch Consumer Research

Update – There is still time to make your submission to PBAC

There is still time to make your submission to PBAC

More Responses Needed for Online Survey (for PBAC submission)

More Responses Needed for Online Survey (for PBAC submission)

Online Survey (for PBAC submission)

Online Survey (for PBAC submission)